AbbVie, Inc. is a large biopharmaceutical research and development company. Its filings show it lobbies Congress mainly on Medicare and Medicaid rules, including Medicare Part D drug coverage, the 340B hospital drug discount program, and parts of the Inflation Reduction Act that affect drug pricing and industry oversight. It also works on patient access to therapies and issues involving pharmacy benefit managers (PBMs).
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
KAADE WALLACE
The latest disclosures for this client.
FEDERAL STREET STRATEGIES, LLC
Q2FEDERAL STREET STRATEGIES, LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FEDERAL STREET STRATEGIES, LLC
PAUL BRATHWAITE
FEDERAL STREET STRATEGIES, LLC
STACEY LEAVANDOSKY
FEDERAL STREET STRATEGIES, LLC
VEN NERALLA
FEDERAL STREET STRATEGIES, LLC
MARGAUX OCHOA
FEDERAL STREET STRATEGIES, LLC
FEDERAL STREET STRATEGIES, LLC
Q4FEDERAL STREET STRATEGIES, LLC
Q3FEDERAL STREET STRATEGIES, LLC
Q2FEDERAL STREET STRATEGIES, LLC
Q1